entrinsic bioscience
Dr. Turner has, for over 25 years, led an NIH- and foundation-funded research program focused on gastrointestinal mucosal barrier function. The goals of this program are to understand the molecular mechanisms that build and maintain mucosal barriers to define the impact of barrier regulation and dysregulation on health and disease. His work has led to fundamental advances that have generated new paradigms of mucosal barrier regulation in gastrointestinal physiology and pathobiology. Turner’s group has built on these discoveries to develop novel, molecularly-targeted therapeutics that restore mucosal barrier function and shown that these agents can both prevent and treat experimental disease.
This person is not in the org chart
This person is not in any offices
entrinsic bioscience
entrinsic bioscience is a recognized leader in the development, manufacturing and commercialization of disruptive, science-derived amino-acid technologies that are clinically-proven to deliver better health outcomes in a broad range of therapeutic areas including gut health, hydration, skin and respiratory health.